US FDA approves CTI BioPharma’s bone marrow cancer drug
The drug, Vonjo (pacritinib), belongs to a class of anti-inflammatory treatments called JAK inhibitors, and will compete with…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.